|
1
|
Dai J, Zou T, Wang L, Zhang Y and Liu Y:
Investigation of the interaction between quercetin and human serum
albumin by multiple spectra, electrochemical impedance spectra and
molecular modeling. Luminescence. 29:1154–1161. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhong L, Zhang X and Covasa M: Emerging
roles of lactic acid bacteria in protection against colorectal
cancer. World J Gastroenterol. 20:7878–7886. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dueland S, Hagness M, Line PD, Guren TK,
Tveit KM and Foss A: Is liver transplantation an option in
colorectal cancer patients with nonresectable liver metastases and
progression on all lines of standard chemotherapy? Ann Surg Oncol.
22:2195–2200. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cleven AH, Derks S, Draht MX, Smits KM,
Melotte V, Van Neste L, Tournier B, Jooste V, Chapusot C,
Weijenberg MP, et al: CHFR promoter methylation indicates poor
prognosis in stage II microsatellite stable colorectal cancer. Clin
Cancer Res. 20:3261–3271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen P, Xi Q, Wang Q and Wei P:
Downregulation of microRNA-100 correlates with tumor progression
and poor prognosis in colorectal cancer. Med Oncol. 31:2352014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Adams SV, Newcomb PA, Burnett-Hartman AN,
Wurscher MA, Mandelson M, Upton MP, Zhu LC, Potter JD and Makar KW:
Rare circulating microRNAs as biomarkers of colorectal neoplasia.
PLoS One. 9:e1086682014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Drusco A, Nuovo GJ, Zanesi N, Di Leva G,
Pichiorri F, Volinia S, Fernandez C, Antenucci A, Costinean S,
Bottoni A, et al: MicroRNA profiles discriminate among colon cancer
metastasis. PLoS One. 9:e966702014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liang G, Li J, Sun B, Li S, Lü L, Wang Y,
Chen B and Xiao Z: Deep sequencing reveals complex mechanisms of
microRNA deregulation in colorectal cancer. Int J Oncol.
45:603–610. 2014.PubMed/NCBI
|
|
9
|
Phua LC, Chue XP, Koh PK, Cheah PY, Chan
EC and Ho HK: Global fecal microRNA profiling in the identification
of biomarkers for colorectal cancer screening among Asians. Oncol
Rep. 32:97–104. 2014.PubMed/NCBI
|
|
10
|
Yin J, Bai Z, Song J, Yang Y, Wang J, Han
W, Zhang J, Meng H, Ma X, Yang Y, et al: Differential expression of
serum miR-126, miR-141 and miR-21 as novel biomarkers for early
detection of liver metastasis in colorectal cancer. Chin J Cancer
Res. 26:95–103. 2014.PubMed/NCBI
|
|
11
|
Haque I, Banerjee S, Mehta S, De A,
Majumder M, Mayo MS, Kambhampati S, Campbell DR and Banerjee SK:
Cysteine-rich 61-connective tissue growth factor-nephroblastoma
overexpressed 5 (CCN5)/Wnt-1-induced signaling protein-2 (WISP-2)
regulates microRNA-10b via hypoxia-inducible factor-1α-TWIST
signaling networks in human breast cancer cells. J Biol Chem.
286:43475–43485. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu Z, Zhu J, Cao H, Ren H and Fang X:
MiR-10b promotes cell invasion through RhoC-AKT signaling pathway
by targeting HOXD10 in gastric cancer. Int J Oncol. 40:1553–1560.
2012.PubMed/NCBI
|
|
13
|
Yu X, Li Z, Shen J, Wu WK, Liang J, Weng X
and Qiu G: MicroRNA-10b promotes nucleus pulposus cell
proliferation through RhoC-Akt pathway by targeting HOXD10 in
intervetebral disc degeneration. PLoS One. 8:e830802013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bu Q, Tang HM, Tan J, Hu X and Wang DW:
Expression of RhoC and ROCK-1 and their effects on MAPK and Akt
proteins in prostate carcinoma. Zhonghua Zhong Liu Za Zhi.
33:202–206. 2011.(In Chinese). PubMed/NCBI
|
|
15
|
Nishida N, Yamashita S, Mimori K, Sudo T,
Tanaka F, Shibata K, Yamamoto H, Ishii H, Doki Y and Mori M:
MicroRNA-10b is a prognostic indicator in colorectal cancer and
confers resistance to the chemotherapeutic agent 5-fluorouracil in
colorectal cancer cells. Ann Surg Oncol. 19:3065–3071. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang YF, Li Z, Zhao XH, Zuo XM, Zhang Y,
Xiao YH, Li J and Peng ZH: MicroRNA-10b is upregulated and has an
invasive role in colorectal cancer through enhanced Rhoc
expression. Oncol Rep. 33:1275–1283. 2015.PubMed/NCBI
|
|
17
|
von Winterfeld M, Hoffmeister M,
Ingold-Heppner B, Jansen L, Tao S, Herpel E, Schirmacher P, Dietel
M, Chang-Claude J, Autschbach F, et al: Frequency of
therapy-relevant staging shifts in colorectal cancer through the
introduction of pN1c in the 7th TNM edition. Eur J Cancer.
50:2958–2965. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rickham PP: Human experimentation. Code of
ethics of the World Medical Association. Declaration of Helsinki.
Br Med J. 2:1771964. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang L, Chen S, Xue M, Zhong J, Wang X,
Gan L, Lam EK, Liu X, Zhang J, Zhou T, et al: Homeobox D10 gene, a
candidate tumor suppressor, is downregulated through promoter
hypermethylation and associated with gastric carcinogenesis. Mol
Med. 18:389–400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xiao H, Li H, Yu G, Xiao W, Hu J, Tang K,
Zeng J, He W, Zeng G, Ye Z and Xu H: MicroRNA-10b promotes
migration and invasion through KLF4 and HOXD10 in human bladder
cancer. Oncol Rep. 31:1832–1838. 2014.PubMed/NCBI
|
|
21
|
Xue M, Fang Y, Sun G, Zhuo W, Zhong J,
Qian C, Wang L, Wang L, Si J and Chen S: IGFBP3, a transcriptional
target of homeobox D10, is correlated with the prognosis of gastric
cancer. PLoS One. 8:e814232013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen W, Cai F, Zhang B, Barekati Z and
Zhong XY: The level of circulating miRNA-10b and miRNA-373 in
detecting lymph node metastasis of breast cancer: Potential
biomarkers. Tumour Biol. 34:455–462. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Severino P, Brüggemann H, Andreghetto FM,
Camps C, Klingbeil Mde F, de Pereira WO, Soares RM, Moyses R,
Wünsch-Filho V, Mathor MB, et al: MicroRNA expression profile in
head and neck cancer: HOX-cluster embedded microRNA-196a and
microRNA-10b dysregulation implicated in cell proliferation. BMC
Cancer. 13:5332013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yigit MV, Ghosh SK, Kumar M, Petkova V,
Kavishwar A, Moore A and Medarova Z: Context-dependent differences
in miR-10b breast oncogenesis can be targeted for the prevention
and arrest of lymph node metastasis. Oncogene. 32:1530–1538. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guessous F, Alvarado-Velez M,
Marcinkiewicz L, Zhang Y, Kim J, Heister S, Kefas B, Godlewski J,
Schiff D, Purow B and Abounader R: Oncogenic effects of miR-10b in
glioblastoma stem cells. J Neurooncol. 112:153–163. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Karsy M, Arslan E and Moy F: Current
progress on understanding MicroRNAs in glioblastoma multiforme.
Genes Cancer. 3:3–15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xue Y, Abou Tayoun AN, Abo KM, Pipas JM,
Gordon SR, Gardner TB, Barth RJ Jr, Suriawinata AA and Tsongalis
GJ: MicroRNAs as diagnostic markers for pancreatic ductal
adenocarcinoma and its precursor, pancreatic intraepithelial
neoplasm. Cancer Genet. 206:217–221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Moghimi-Dehkordi B and Safaee A: An
overview of colorectal cancer survival rates and prognosis in Asia.
World J Gastrointest Oncol. 4:71–75. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sarkar S, Mukherjee R, Paira SK, Roy B,
Banerjee S and Mukherjee SK: Profile of colorectal cancer in
Eastern India. J Indian Med Assoc. 110:901–903. 2012.PubMed/NCBI
|
|
30
|
Wong MC, Lam TY, Tsoi KK, Chan VC, Hirai
HW, Ching JY and Sung JJ: Predictors of advanced colorectal
neoplasia for colorectal cancer screening. Am J Prev Med.
46:433–439. 2014. View Article : Google Scholar : PubMed/NCBI
|
